A detailed history of Bank Of Montreal transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Bank Of Montreal holds 13,303 shares of ADPT stock, worth $76,492. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,303
Holding current value
$76,492
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.34 - $3.96 $31,129 - $52,679
13,303 New
13,303 $48,000
Q1 2023

Jun 13, 2024

BUY
$7.8 - $10.11 $96,961 - $125,677
12,431 New
12,431 $109,000
Q3 2022

Nov 10, 2022

BUY
$6.5 - $12.67 $16,978 - $33,094
2,612 Added 15.8%
19,145 $137,000
Q2 2022

Aug 11, 2022

SELL
$6.4 - $14.73 $485,843 - $1.12 Million
-75,913 Reduced 82.12%
16,533 $142,000
Q1 2022

May 12, 2022

BUY
$10.12 - $28.9 $935,553 - $2.67 Million
92,446 New
92,446 $1.28 Million
Q4 2021

Feb 11, 2022

SELL
$25.17 - $36.85 $167,657 - $245,457
-6,661 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$30.02 - $39.87 $199,963 - $265,574
6,661 New
6,661 $219,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $822M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.